NYSE:WMK
NYSE:WMKConsumer Retailing

Undiscovered Gems in the US Market for December 2025

As the U.S. stock market experiences a mixed performance with major indices hovering near record highs, investors are closely watching key economic indicators and upcoming inflation data that could influence Federal Reserve decisions. In this environment, small-cap stocks often present unique opportunities for growth due to their potential to capitalize on niche markets and innovative solutions, making them intriguing options for those seeking undiscovered gems in the market.
NasdaqCM:FMNB
NasdaqCM:FMNBBanks

Top 3 Dividend Stocks To Consider For Your Portfolio

As the U.S. stock market navigates a mixed performance with major indexes like the Dow and S&P 500 nearing record highs, investors are keenly watching economic indicators such as inflation data that could impact future interest rate decisions. In this environment, dividend stocks can offer a reliable income stream and potential stability, making them an attractive consideration for those looking to balance growth with income in their portfolios.
NYSE:TFIN
NYSE:TFINBanks

Triumph Financial (TFIN): Valuation Check After Creative Planning’s New Position Spurs Share Price Rebound

Triumph Financial, Inc. saw its stock jump after a regulatory filing showed that institutional investor Creative Planning opened a new position, a move that is often interpreted as signaling fresh confidence in a bank's long term trajectory. See our latest analysis for Triumph Financial. The buying interest from Creative Planning comes as Triumph’s share price has rebounded in the short term, with an 11.85% 7 day share price return and 12.65% 30 day share price return. However, this sits...
NYSE:BK
NYSE:BKCapital Markets

Is It Too Late to Consider BNY Mellon After Its 47% Year to Date Surge?

If you are wondering whether Bank of New York Mellon is still good value after its big run, you are not alone. This is exactly what we are going to unpack. The stock has climbed 2.3% over the last week, 5.5% over the last month and is now up a striking 47.2% year to date, with 42.9% over 1 year, 178.6% over 3 years and 218.3% over 5 years. This naturally raises the question of how much upside might be left. Recent headlines have focused on how large custody banks like BNY Mellon are...
NYSE:GWW
NYSE:GWWTrade Distributors

Assessing W.W. Grainger (GWW) Valuation After Its Recent Share Price Pullback

W.W. Grainger (GWW) has been drifting lower this year after a very strong multi year run, leaving some long term holders wondering whether the recent pullback is a reset or an opportunity. See our latest analysis for W.W. Grainger. At around $968.91 per share, the recent slide has pulled W.W. Grainger’s year to date share price return into negative territory. Its five year total shareholder return still reflects a very strong long term compounding story, which suggests momentum has cooled...
NYSE:SPG
NYSE:SPGRetail REITs

Is Simon Property Group Still Attractive After a 165% Multi Year Share Price Surge?

Wondering whether Simon Property Group is still worth buying after its big multi year run, or if most of the easy gains are already behind it? You are not alone, and that is exactly what we will unpack here. The stock now trades around $183.32, up a hefty 165.3% over five years and 81.8% over three years, even though shorter term returns have cooled, with the share price roughly flat over 30 days and up about 5.8% over the past year. Recent headlines have focused on Simon doubling down on...
NasdaqGS:URBN
NasdaqGS:URBNSpecialty Retail

Urban Outfitters (URBN) Valuation Check After Record Q3 Earnings Beat and Broad-Based Sales Momentum

Urban Outfitters (URBN) just reported a record third quarter, beating expectations on both earnings and revenue as every brand and region posted positive comparable sales, giving investors fresh reason to revisit the stock. See our latest analysis for Urban Outfitters. The stock has had a choppy reaction to the news, with the share price slipping 4.38% over the last day to $75.72. However, a 30 day share price return of 17.41% and a standout 1 year total shareholder return of 51.5% suggest...
NYSE:MOH
NYSE:MOHHealthcare

Did Lawsuits Over Cost Assumptions and Guidance Cuts Just Shift Molina Healthcare's (MOH) Investment Narrative?

Molina Healthcare has recently become the subject of multiple securities class action lawsuits and shareholder investigations alleging failures to disclose material adverse information about its medical cost trend assumptions, premium rate misalignment, and 2025 financial guidance cuts. These legal actions highlight concerns not just about current earnings pressure, but also about governance, disclosure practices, and how reliably investors can assess Molina’s underlying medical cost...
NYSE:HIMS
NYSE:HIMSHealthcare

Is It Too Late To Consider Hims & Hers After Its 452% Three Year Surge?

If you are wondering whether Hims & Hers Health is still a smart buy after its huge run, or if the easy money has already been made, this breakdown will help you decide whether the current price still stacks up against the fundamentals. The stock has cooled off a bit in the last month, down 6.5%, but that follows a powerful 58.8% gain year to date and a massive 452.0% jump over 3 years that has completely changed how the market views the business. Recent headlines have focused on Hims & Hers...